BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 24, 2016
View Archived Issues
Emulate enters translational R&D collaboration
Read More
Roche reviews highlights of third quarter 2016
Read More
TxCell and UBC begin strategic collaboration to develop CAR-Tregs in solid organ transplantation
Read More
BlackThorn Therapeutics closes series A financing
Read More
Merck & Co. patents BTK inhibitors
Read More
Rigel Pharmaceuticals discloses TGF-beta and/or GDF-8 inhibitors
Read More
MedImmune begins phase I study of anti-ILT-7 antibody
Read More
AbbVie describes TRPV3 receptor antagonists
Read More
FDA approves Zinplava to reduce recurrence of C. difficile infection
Read More
FDA approves updated labeling for Xtandi
Read More
Gilead Sciences reports results of three phase II studies of selonsertib
Read More
Merck & Co.'s KEYNOTE-045 study meets primary endpoint
Read More
Daiichi Sankyo updates decision on phase III study of pexidartinib in tenosynovial giant cell tumor
Read More
Bristol-Myers Squibb develops IDO inhibitors
Read More
Phase II results on OMS-721 in stem cell transplant-associated thrombotic microangiopathy
Read More
Daiichi Sankyo reports Japanese phase III results for prasugrel in ischemic cerebrovascular disease
Read More
Gilead Sciences provides results from phase III studies of sofosbuvir/velpatasvir/voxilaprevir
Read More
Phase III efficacy trials of revefenacin in COPD meet primary endpoint
Read More
NeuroVive and Arbutus terminate NVP-018 agreement
Read More
FDA committee votes in favor of approving SER-120 for nocturia
Read More
FDA accepts resubmitted NDA for safinamide
Read More
Phase III study of denosumab in MM meets primary enpoint
Read More
VBI-1901 shows promising preclinical results
Read More
GSK submits BLA for Shingrix
Read More
Janssen presents phase I results for ExPEC4v
Read More
Multiplatform imaging of systemic amyloidosis with the new peptide p5+14
Read More
New mutations in known disease-associated genes
Read More
Discovery of new biomarkers for conditions
Read More